Edwards Lifesciences (NYSE:EW) recently celebrated the FDA approval of its SAPIEN 3 TAVR therapy for asymptomatic aortic stenosis patients, a significant development in cardiac care. This milestone, ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.

A pioneering heart centre at Basildon Hospital is celebrating a major milestone after carrying out its 1,000th "life-changing procedure". The Essex Cardiothoracic Centre (CTC), based at Basildon ...